Modulators of central nervous system neurotransmitters
    1.
    发明授权
    Modulators of central nervous system neurotransmitters 有权
    中枢神经系统神经递质调节剂

    公开(公告)号:US08168635B2

    公开(公告)日:2012-05-01

    申请号:US11629797

    申请日:2005-06-20

    申请人: John Cashman

    发明人: John Cashman

    IPC分类号: A61K31/502 C07D237/30

    摘要: Disclosed are agents having pharmacological activity against cellular receptors and intracellular signaling, particularly receptors and signaling pathways of central nervous system (CNS) neurotransmitters. Also disclosed are related methods and compositions for the treatment or prevention of diseases or disorders using the agents.

    摘要翻译: 公开了具有针对细胞受体和细胞内信号传导的药理学活性的试剂,特别是中枢神经系统(CNS)神经递质的受体和信号通路。 还公开了使用这些试剂治疗或预防疾病或病症的相关方法和组合物。

    MODULATORS OF CENTRAL NERVOUS SYSTEM NEUROTRANSMITTERS
    3.
    发明申请
    MODULATORS OF CENTRAL NERVOUS SYSTEM NEUROTRANSMITTERS 审中-公开
    中枢神经系统神经递质调节器

    公开(公告)号:US20130123253A1

    公开(公告)日:2013-05-16

    申请号:US13461677

    申请日:2012-05-01

    申请人: John CASHMAN

    发明人: John CASHMAN

    摘要: Disclosed are agents having pharmacological activity against cellular receptors and intracellular signaling, particularly receptors and signaling pathways of central nervous system (CNS) neurotransmitters. Also disclosed are related methods and compositions for the treatment or prevention of diseases or disorders using the agents.

    摘要翻译: 公开了具有针对细胞受体和细胞内信号传导的药理学活性的试剂,特别是中枢神经系统(CNS)神经递质的受体和信号通路。 还公开了使用这些试剂治疗或预防疾病或病症的相关方法和组合物。

    SMALL MOLECULE COMPOUNDS FOR STEM CELL DIFFERENTIATION
    10.
    发明申请
    SMALL MOLECULE COMPOUNDS FOR STEM CELL DIFFERENTIATION 有权
    小分子化合物用于干细胞分化

    公开(公告)号:US20100159596A1

    公开(公告)日:2010-06-24

    申请号:US12561235

    申请日:2009-09-16

    摘要: Methods and small molecule compounds for stem cell differentiation are provided. One example of a class of compounds that may be used is represented by the compound having the structure IA or IB in the form of free base or a pharmaceutically acceptable salt, hydrate, solvate or N-oxide thereof: R1 is independently hydrogen or (C1-C6)alkyl; R2 is independently hydrogen, (C1-C6)alkyl, aryl, or heteroaryl; R2′ is independently hydrogen, (C1-C6)alkyl, CF3 or C2F5; R3 is independently (C1-C6)alkyl, aryl, 2-tetrahydrofurylmethyl, an aliphatic tertiary amine, or 4-methoxybenzyl; or R2 and R3 may be joined together to form a 5 or 6 member ring lactone; R4 is independently hydrogen, (C1-C6)alkyl, a 2- or 4-R5-substituted aromatic ring selected from a 4-R5-phenyl or a 2-R5-5-pyridyl, aryl, heteroaryl, aliphatic tertiary amine or halogen; and R5, R5′, R6, R6′, R7, R7′, are each independently hydrogen, (C1-C6)alkyl, aryl, optionally substituted phenyl, heteroaryl, a heterocyclic ring, an aliphatic tertiary amine, or halogen.

    摘要翻译: 提供了干细胞分化的方法和小分子化合物。 可以使用的一类化合物的一个实例由具有游离碱或其药学上可接受的盐,水合物,溶剂合物或N-氧化物形式的结构IA或IB的化合物表示:R1独立地是氢或(C1 -C 6)烷基; R2独立地是氢,(C1-C6)烷基,芳基或杂芳基; R2'独立地是氢,(C1-C6)烷基,CF3或C2F5; R3独立地为(C1-C6)烷基,芳基,2-四氢呋喃基甲基,脂肪族叔胺或4-甲氧基苄基; 或者R 2和R 3可以连接在一起以形成5或6元环内酯; R4独立地为氢,(C1-C6)烷基,选自4-R5-苯基或2-R5-5-吡啶基,芳基,杂芳基,脂族叔胺或卤素的2或4-R 5 - 取代的芳环 ; 和R 5,R 5',R 6,R 6',R 7,R 7'各自独立地为氢,(C 1 -C 6)烷基,芳基,任选取代的苯基,杂芳基,杂环,脂族叔胺或卤素。